These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10485477)

  • 1. The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptor.
    Schafer JI; Liu H; Tonetti DA; Jordan VC
    Cancer Res; 1999 Sep; 59(17):4308-13. PubMed ID: 10485477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D; Dardes R; Liu H; MacGregor-Schafer J; Zapf J; Jordan V
    Endocrinology; 2001 Feb; 142(2):838-46. PubMed ID: 11159857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor.
    Levenson AS; Catherino WH; Jordan VC
    J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):261-8. PubMed ID: 9219916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells.
    Simard J; Sanchez R; Poirier D; Gauthier S; Singh SM; Merand Y; Belanger A; Labrie C; Labrie F
    Cancer Res; 1997 Aug; 57(16):3494-7. PubMed ID: 9270018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta.
    Tremblay A; Tremblay GB; Labrie C; Labrie F; Giguère V
    Endocrinology; 1998 Jan; 139(1):111-8. PubMed ID: 9421405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.
    Labrie F; Labrie C; Bélanger A; Simard J; Gauthier S; Luu-The V; Mérand Y; Giguere V; Candas B; Luo S; Martel C; Singh SM; Fournier M; Coquet A; Richard V; Charbonneau R; Charpenet G; Tremblay A; Tremblay G; Cusan L; Veilleux R
    J Steroid Biochem Mol Biol; 1999; 69(1-6):51-84. PubMed ID: 10418981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cells.
    Levenson AS; Svoboda KM; Kwaan HC; Jordan VC
    Cancer Lett; 1998 Mar; 125(1-2):215-20. PubMed ID: 9566718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model to describe how a point mutation of the estrogen receptor alters the structure-function relationship of antiestrogens.
    Jiang SY; Parker CJ; Jordan VC
    Breast Cancer Res Treat; 1993; 26(2):139-47. PubMed ID: 8219251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor.
    Levenson AS; Jordan VC
    Cancer Res; 1998 May; 58(9):1872-5. PubMed ID: 9581827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
    Martel C; Labrie C; Bélanger A; Gauthier S; Mérand Y; Li X; Provencher L; Candas B; Labrie F
    Endocrinology; 1998 May; 139(5):2486-92. PubMed ID: 9564862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.
    Diel P; Olff S; Schmidt S; Michna H
    J Steroid Biochem Mol Biol; 2002 Jan; 80(1):61-70. PubMed ID: 11867264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure antiestrogens and breast cancer.
    Elkak AE; Mokbel K
    Curr Med Res Opin; 2001; 17(4):282-9. PubMed ID: 11922402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of the estrogen-like actions of the tamoxifen-estrogen receptor complex by the surface amino acid at position 351.
    Levenson AS; MacGregor Schafer JI; Bentrem DJ; Pease KM; Jordan VC
    J Steroid Biochem Mol Biol; 2001; 76(1-5):61-70. PubMed ID: 11384864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
    Poulin R; Merand Y; Poirier D; Levesque C; Dufour JM; Labrie F
    Breast Cancer Res Treat; 1989 Oct; 14(1):65-76. PubMed ID: 2605344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro.
    Simard J; Labrie C; Bélanger A; Gauthier S; Singh SM; Mérand Y; Labrie F
    Int J Cancer; 1997 Sep; 73(1):104-12. PubMed ID: 9334816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells.
    Liu H; Park WC; Bentrem DJ; McKian KP; Reyes Ade L; Loweth JA; Schafer JM; Zapf JW; Jordan VC
    J Biol Chem; 2002 Mar; 277(11):9189-98. PubMed ID: 11751902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.
    Levenson AS; Gehm BD; Pearce ST; Horiguchi J; Simons LA; Ward JE; Jameson JL; Jordan VC
    Int J Cancer; 2003 May; 104(5):587-96. PubMed ID: 12594813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J; Kitlen JW; Briand P; Labrie F; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):469-78. PubMed ID: 12732292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.